Common use of Use of Name and Disclosure of Terms Clause in Contracts

Use of Name and Disclosure of Terms. Each Party will keep the existence of, the terms of and the transactions covered by this Agreement confidential and will not disclose such information to any Third Party through a press release or otherwise, or mention or otherwise use the name, insignia, symbol, trademark, trade name or logotype of the other Party or its Affiliates in any manner without the prior written consent of the other Party in each instance (which will not be unreasonably withheld). The restrictions imposed by this Section 5.1.7 will not prohibit either Party from making any disclosure that is required by Applicable Laws or the requirements of a national securities exchange or another similar regulatory body, including disclosing such information in any clinical trial database maintained by or on behalf of a Party, or that is expressly permitted under this Agreement. Further, the restrictions imposed on each Party under this Section 5.1.7 are not intended, and will not be construed, to prohibit a Party from identifying the other Party in its internal business communications, provided that any Confidential Information in such communications remains subject to this Section 5.1.7.

Use of Name and Disclosure of Terms. Each Party will keep the existence of, the terms of and the transactions covered by this Agreement confidential and will not disclose such information to any Third Party through a press release or otherwise, or mention or otherwise use the name, insignia, symbol, trademark, trade name or logotype of the other Party or its Affiliates in any manner without the prior written consent of the other Party in each instance (which will not be unreasonably withheld). The restrictions imposed by this Section 5.1.7 will not prohibit either Party from making any disclosure that is required by Applicable 178 Laws or the requirements of a national securities exchange or another similar regulatory body, including disclosing such information in any clinical trial database maintained by or on behalf of a Party, or that is expressly permitted under this Agreement. Further, the restrictions imposed on each Party under this Section 5.1.7 are not intended, and will not be construed, to prohibit a Party from identifying the other Party in its internal business communications, provided that any Confidential Information in such communications remains subject to this Section 5.1.7.

Use of Name and Disclosure of Terms. Each Party will keep the existence of, the terms of of, and the transactions covered by this Agreement confidential and will not disclose such information to any Third Party other Person through a press release or otherwise, or mention or otherwise use the name, insignia, symbol, trademark, trade name name, or logotype of the other Party or its Affiliates in any manner without the prior written consent of the other Party in each instance (which will not be unreasonably withheld). The restrictions imposed by this Section 5.1.7 5.1.6 will not prohibit either Party from making any disclosure that is required by Applicable Laws Law, rule, or regulation or the requirements of a national securities exchange or another similar regulatory body, body including disclosing such information in any clinical trial database maintained by or on behalf of a Party, or that is expressly permitted under this Agreement. Further, the restrictions imposed on each Party under this Section 5.1.7 5.1.6 are not intended, and will not be construed, to prohibit a Party from identifying the other Party in its internal business communications, provided that any Confidential Information in such communications remains subject to this Section 5.1.75.1.6.

Use of Name and Disclosure of Terms. Each Party will shall keep the existence of, the terms of and the transactions covered by this Agreement confidential and will shall not disclose such information to any Third Party other Person through a press release or otherwise, or mention or otherwise use the name, insignia, symbol, trademark, trade name or logotype of the other Party or its Affiliates in any manner without the prior written consent of the other Party in each instance (which will shall not be unreasonably withheld). The restrictions imposed by this Section 5.1.7 will shall not prohibit either Party from making any disclosure that is required by Applicable Laws Law, rule or regulation or the requirements of a national securities exchange or another similar regulatory body, body including disclosing such information in any clinical trial database maintained by or on behalf of a Party, or that is expressly permitted under this Agreement. Further, the restrictions imposed on each Party under this Section 5.1.7 6.1.6 are not intended, and will shall not be construed, to prohibit a Party from identifying the other Party in its internal business communications, provided that any Confidential Information in such communications remains subject to this Section 5.1.76.1.6.

Use of Name and Disclosure of Terms. Each Party will keep the existence of, the terms of of, and the transactions covered by this Agreement confidential and will not disclose such information to any Third Party other Person through a press release or otherwise, or mention or otherwise use the name, insignia, symbol, trademark, trade name name, or logotype of the other Party or its Affiliates in any manner without the prior written consent of the other Party in each instance (which will not be unreasonably withheld). The restrictions imposed by this Section 5.1.7 3.1(f) will not prohibit either Party from making any disclosure that is required by Applicable Laws Law, rule, or regulation or the requirements of a national securities exchange or another similar regulatory body, body including disclosing such information in any clinical trial database maintained by or on behalf of a Party, or that is expressly permitted under this Agreement. Further, the restrictions imposed on each Party under this Section 5.1.7 3.1(f) are not intended, and will not be construed, to prohibit a Party from identifying the other Party in its internal business communications, provided that any Confidential Information in such communications remains subject to this Section 5.1.73.1(f).

Use of Name and Disclosure of Terms. Each Party will keep the existence of, the terms of of, and the transactions covered by this Agreement confidential and will not disclose such information to any Third Party other Person through a press release or otherwise, or mention or otherwise use the name, insignia, symbol, trademark, trade name name, or logotype of the other Party or its Affiliates in any manner without the prior written consent of the other Party in each instance (which will not be unreasonably withheld). The restrictions imposed by this Section 5.1.7 3.1(f) will not prohibit either Party from making any disclosure that is required by Applicable Laws Law, rule, or regulation or the requirements of a national securities exchange or another similar regulatory body, body including disclosing such information in any clinical trial database maintained by or on behalf of a Party, or that is expressly permitted under this Agreement. Further, the restrictions imposed on each Party under this Section 5.1.7 3.1(f) are not intended, and will not be construed, to prohibit a Party from identifying the other Party in its internal business communications, provided that any Confidential Information in such communications remains subject to this Section 5.1.7.3.1(f). (g)